22.64
Schlusskurs vom Vortag:
$24.00
Offen:
$24.21
24-Stunden-Volumen:
1.22M
Relative Volume:
1.49
Marktkapitalisierung:
$1.65B
Einnahmen:
$193.35M
Nettoeinkommen (Verlust:
$-177.58M
KGV:
-9.2408
EPS:
-2.45
Netto-Cashflow:
$-172.43M
1W Leistung:
-8.89%
1M Leistung:
+6.14%
6M Leistung:
+12.69%
1J Leistung:
-24.61%
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Vergleichen Sie SDGR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SDGR
Schrodinger Inc
|
22.64 | 1.65B | 193.35M | -177.58M | -172.43M | -2.45 |
![]()
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
![]()
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
2022-12-19 | Eingeleitet | Goldman | Neutral |
2022-03-01 | Eingeleitet | Citigroup | Buy |
2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
2021-10-13 | Eingeleitet | Berenberg | Buy |
2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-05-25 | Eingeleitet | Craig Hallum | Buy |
2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
2020-03-02 | Eingeleitet | Jefferies | Hold |
2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Baillie Gifford & Co. - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Schrödinger (NASDAQ:SDGR) Shares Gap UpStill a Buy? - MarketBeat
(SDGR) Trading Advice - Stock Traders Daily
Schrödinger (SDGR) Projected to Post Earnings on Wednesday - MarketBeat
Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Stanley Laman Group Ltd. - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Yousif Capital Management LLC - Defense World
Hunterbrook Capital long ‘key AI winner’ Schrodinger - MSN
Schrödinger: An Interesting Investment With Immense Potential - Seeking Alpha
Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI - MSN
Schrodinger Stock Scores IBD Rating Upgrade - MSN
Schrodinger EVP Yvonne Tran sells $20,228 in stock - MSN
Sumitomo Mitsui Trust Group Inc. Acquires 1,319,464 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger EVP Kenneth Lorton sells $24,063 in common stock - MSN
Stephens Investment Management Group LLC Has $31.01 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger SVP Jenny Herman sells shares for $20,985 By Investing.com - Investing.com Australia
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26 - BioSpace
Schrodinger EVP Yvonne Tran sells $20,228 in stock By Investing.com - Investing.com Nigeria
Schrodinger SVP Jenny Herman sells shares for $20,985 - Investing.com
Schrodinger EVP Kenneth Lorton sells $24,063 in common stock By Investing.com - Investing.com South Africa
Schrodinger Executives Sell Shares to Cover Tax Liabilities - TradingView
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Schrodinger Inc (SDGR) Shares Up 4.21% on Feb 5 - GuruFocus.com
Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Schrodinger stock soars; Hunterbrook positive as AI integration promises drug discovery advances - MSN
Top 5 AI & Digital Biotech Companies (February 2025) - Securities.io
Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss - Yahoo Finance
First Week of February 21st Options Trading For Schrodinger (SDGR) - Nasdaq
Schrodinger Inc to Host Earnings Call - ACCESS Newswire
Schrodinger (SDGR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
10 AI News And Ratings on Wall Street’s Radar - Insider Monkey
Schrödinger Adopts the Sapio Platform to Enhance In Silico Drug Discovery - Contract Pharma
(SDGR) Investment Analysis - Stock Traders Daily
AI Pharma: 2 Paths to AI-Powered Drug Investment - MarketBeat
Schrödinger (NASDAQ:SDGR) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
KeyCorp Raises Schrödinger (NASDAQ:SDGR) Price Target to $27.00 - MarketBeat
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Schrodinger Inc-Aktie (SDGR) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Tran Yvonne | EVP, CLO & CPO |
Feb 18 '25 |
Sale |
28.00 |
3,902 |
109,256 |
11,135 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):